Biotecnologia – Portugal


Filed under: Biotecnologia,Eventos — Hugo Azevedo @ 15:01

Pre-Congress Symposium

New Regulatory Developments in Pharmacokinetic Assessment

Auditorium of Faculty of Pharmacy of University of Lisbon

Wednesday, 12th October

= Provisional Programme =

Time Speaker Title

09:00 – 09:30 Leslie Benet Recent developments in Bioavailability assessment

09:30 – 10:00 Monica Edholm The main aspects of the revised Bioequivalence guideline

10:00 – 10:30 Henrike Pothast Biowaivers in the New Bioequivalence Guideline

10:30 – 11:00 Vinod Shah Biowaivers and Dissolution testing

11:00 – 11:30 Coffee break

11:30 – 12:00 Jan Welink The new Bioanalytical Guideline

12:00 – 12:30 Alfredo Garcia Inhalation products

12: 30 – 14:00 Lunch break

14:00 – 14:30



The Current Revision of the Modified Release Guideline

14:30 – 15:00 Kersti Oselin

Regulatory experience with biosimilars and biosimilar Monoclonal


15:00 – 15:30 Coffee break

15:30 – 16:00 Ruth Duncan

Challenges for Determination of the Equivalence of Complex,

Multicomponent Drugs

16:00 – 16:30 Henning Blume BE studies in patient populations – new challenges and future trends


III Congress of the Portuguese Society of Pharmaceutical Sciences

and IX Spanish-Portuguese Conference on Controlled Drug Delivery

New Trends in Pharmaceutical Sciences

13th to 15th October 2011

Auditorium of Association of Portuguese Pharmacies, Oporto

= Provisional Programme =

Thursday, 13th October

9h00m-13h00m Registration

14h30m Opening Ceremony

Session I

15h00m Opening Lecture (title to be defined) – Leslie Benet (Univ. California San Francisco, USA)

15h45m 3 Oral Communications

16h45m Coffee-break

17h15m 2 Oral Communications

17h55m Invited Lecture – “Non-viral vectors and the new opportunities for cellular and

molecular targeting” – João Nuno Moreira (Univ. Coimbra, Portugal)

19h00m Welcome Reception

Friday, 14th October

Session II

9h30m Invited Lecture – (to be defined)

10h15m Coffee-break and Poster Session

11h00m 5 Oral Communications

12h40m Lunch

Session III

14h30m Invited Lecture – “Nanoparticles for drug delivery across biological barriers”

Claus-Michael Lehr (Univ. Saarland, Saarbrücken, Germany) (to be confirmed)

15h15m 3 Oral Communications

16h15m Coffee-break and Poster Session

16h45m-18h00 Round Table “Future Role of Controlled Release in Therapy”

Leslie Benet (Univ. California San Francisco, USA)

Malcolm Rowland (Univ. Manchester, UK)

Ruth Duncan (Univ. Cardiff, UK)

Vinod P. Shah (Univ. of Kentucky, USA)

18h30m General Assembly of SPLC-CRS

18h30m General Assembly of SPCF

21h30m Congress Dinner

Saturday, 15th October

Session IV

9h30m Invited Lecture (title to be defined) – Madalena Pinto (Univ. Porto, Portugal)

10h15m 2 Oral Communications

10h 55m Coffee-break

11h 25m 2 Oral Communications

12h05m Closing Session

Closing Lecture – “An European view of the Pharmaceutical Sciences – Current Thoughts and Future

Perspectives” Malcolm Rowland (Univ. Manchester, UK)

12h50m SPLC-CRS PhD Thesis Award

Oral Communication Award

Poster Award

13h10m Closing Ceremony

13h30m Lunch


Official Website

Workshop Antiparasitic and Antitumor drugs

Filed under: Biotecnologia,Eventos — Hugo Azevedo @ 14:44

8 and 9 of September 2011 at IBMC, Porto, Portugal

Host Institutions: I3S

Deadlines for abstract submission 15 July | Registrations until 31 July


DAY 1: Anti-trypanosomatid drugs: from the clinic to therapeutic targets and drugs

9.00 Welcome

9.20 Leishmaniasis: Clinical manifestations, therapy and threat of drug resistance
Sarman Singh, Rajendra Memorial Research Institute of Medical Sciences, Agamkuan, Patna, India

10.00 New insights on leishmaniasis in immunosuppressive conditions
Javier Moreno, Instituto de Salud Carlos III, Spain

10.40 – 11.10 Coffee break

11.10 In silico approaches to target drug discovery
Nilanjan Roy, National Institute of Pharmaceutical Education and Research, India

11.50 A rational approach for drug targeting with special reference to Leishmania SIR2
Ali Ouaissi, INSERM, Montpellier, France

12.30 – 14.30 Lunch break and poster session I

14.30 The discovery of thiadiaza derivatives as pteridine reductase inhibitors in combinations with pyrimetamine as drugs against Leishmania parasites
Maria Paola Costi, Universita Degli Studi di Modena e Reggio Emilia, Italy

15.10 Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani in Bihar
Pradeep Das, Rajendra Memorial Research Institute Of Medical Sciences. Agam Kuan, Patna, India

15.50-17.20 Coffee break and poster session I (Antiparasitic drugs)

17.20 Hypusine bisynthetic pathway as a novel drug target in L. donovani
R. Madhubala, School of Life Sciences, Jawaharlal Nehru University, New Delhi

18.00 End of the day

18.15 ERA–Net Meeting

DAY 2: Antitumour drugs: from molecular target validation to novel drugs

9.00 Towards new medicines or myths? – The importance of biological target validation in drug discovery
David Haigh, Centre for Cancer Research & Cell Biology, Queen’s University Belfast, UK

9.40 Targeting PI3K/mTOR cell signaling pathway in cancer
Carlos Garcia-Echeverria, Sanofi Aventis, France

10.20 –10.50 Coffee break

10.50 Targeting angiogenesis in cancer
Raquel Soares, FMUP, Portugal

11.30 Classical tumour resistance in the molecular age
Robert O’Connor, NICB, Dublin, Ireland

12.10 – 14.10 Lunch break

14.10 Polyamine derivatives: synthesis and their use in parasitic and cancer diseases?
Paul kong Thoo Lin, Robert Gordon University, Aberdeen, UK

14.50 Selected oral communications I (Antiparasitic drugs) (3x20min)

15.50-17.20 Coffee break and poster session II (Antitumour drugs)

17.20 Selected oral communications II (Antitumour drugs) (3x20min)

18.20 Adjourn

 Official Website